| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |